{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:47Z","timestamp":1786119347194,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/gco.0b013e32832e493e","type":"journal-article","created":{"date-parts":[[2009,8,30]],"date-time":"2009-08-30T03:12:33Z","timestamp":1251601953000},"page":"407-411","source":"Crossref","is-referenced-by-count":18,"title":["Extended cycling or continuous use of hormonal contraceptives for female adolescents"],"prefix":"10.1097","volume":"21","author":[{"given":"Melanie A","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyti","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1542\/peds.111.4.844","article-title":"Relative weight and race influence average age at menarche: results from two nationally representative surveys of US girls studied 25 years apart","volume":"111","author":"Anderson","year":"2003","journal-title":"Pediatrics"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1083-3188(00)00076-0","article-title":"Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives","volume":"14","author":"Davis","year":"2001","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"Seasonale-301 study group: a multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2007.11.005","article-title":"Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens","volume":"77","author":"Vandever","year":"2008","journal-title":"Contraception"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol","volume":"73","author":"Anderson","year":"2006","journal-title":"Contraception"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.contraception.2008.11.011","article-title":"Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive","volume":"79","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.08.004","article-title":"Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg\/ethinyl estradiol 20 \u03bcg (Loestrin 24 Fe)","volume":"75","author":"Nakajima","year":"2007","journal-title":"Contraception"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2004.07.013","article-title":"Endometrial microstructure after long-term use of a 91-day extended-cycle oral contraceptive regimen","volume":"71","author":"Anderson","year":"2005","journal-title":"Contraception"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2007.11.006","article-title":"Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo","volume":"77","author":"Anderson","year":"2008","journal-title":"Contraception"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2006.07.009","article-title":"Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg","volume":"75","author":"Johnson","year":"2007","journal-title":"Contraception"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.contraception.2008.06.015","article-title":"Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on various hemostasis parameters","volume":"78","author":"Wiegratz","year":"2008","journal-title":"Contraception"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","article-title":"Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen","volume":"78","author":"Klipping","year":"2008","journal-title":"Contraception"},{"key":"R22-8-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2005.09.009","article-title":"Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use","volume":"73","author":"Birtch","year":"2006","journal-title":"Contraception"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"186","author":"Sulak","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(02)00445-6","article-title":"Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial","volume":"67","author":"Kwiecien","year":"2003","journal-title":"Contraception"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous vs. cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-8-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(01)02951-X","article-title":"Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis","volume":"77","author":"Vercellini","year":"2002","journal-title":"Fertil Steril"},{"key":"R29-8-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jadohealth.2006.09.013","article-title":"Extended cycling of combined hormonal contraceptives in adolescents: physician views and prescribing practices","volume":"40","author":"Gerschultz","year":"2007","journal-title":"J Adolesc Health"},{"key":"R30-8-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0010-7824(93)80141-H","article-title":"Long-interval treatment regiment with a desogestrel-containing oral contraceptive.","volume":"l48","author":"Cachrimandidou","year":"1993","journal-title":"Contraception"},{"issue":"Suppl 2","key":"R31-8-20210129","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32526-9","article-title":"The Society of Obstetricians and Gynecologists of Canada. Canadian consensus guideline on continuous and extended cycle hormonal contraception","volume":"2997","author":"Guilbert","year":"2007","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GCO.0b013e32832e493e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:04:51Z","timestamp":1786039491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-200910000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e32832e493e","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}